PD-L1 ELISA试剂盒

Wang, Huang, Lu, Liu, Mo: "Immuno-protective vesicle-crosslinked hydrogel for allogenic transplantation." in: Nature communications, Vol. 15, Issue 1, pp. 5176, (2024) (PubMed).

Kim, Lee, Kim, Suh, Nam, Bang, Jin, Oh, Kim, Kim, Oh: "The prognostic role of soluble transforming growth factor-β and its correlation with soluble programmed death-ligand 1 in biliary tract cancer." in: Liver international : official journal of the International Association for the Study of the Liver, Vol. 41, Issue 2, pp. 388-395, (2021) (PubMed).

Wang, Li, Duan, Yuan, Mor, Liao: "Identification of programmed cell death 1 and its ligand in the testicular tissue of mice." in: American journal of reproductive immunology (New York, N.Y. : 1989), Vol. 81, Issue 2, pp. e13079, (2020) (PubMed).

Park, Bang, Nam, Eun Park, Hua Jin, Bang, Oh: "Prognostic implications of soluble programmed death-ligand 1 and its dynamics during chemotherapy in unresectable pancreatic cancer." in: Scientific reports, Vol. 9, Issue 1, pp. 11131, (2020) (PubMed).

Kim, Sun, Yoon, Ko, Won, Kim: "Clinical implications of APOBEC3A and 3B expression in patients with breast cancer." in: PLoS ONE, Vol. 15, Issue 3, pp. e0230261, (2020) (PubMed).

Avendaño-Ortiz, Rubio-Garrido, Lozano-Rodríguez, Del Romero, Rodríguez, Moreno, Aguirre, Holguín, López-Collazo: "Soluble PD-L1: a potential immune marker for HIV-1 infection and virological failure." in: Medicine, Vol. 99, Issue 20, pp. e20065, (2020) (PubMed).

Omura, Toiyama, Okugawa, Yin, Shigemori, Kusunoki, Kusunoki, Ide, Shimura, Fujikawa, Yasuda, Hiro, Ohi, Kusunoki: "Prognostic impacts of tumoral expression and serum levels of PD-L1 and CTLA-4 in colorectal cancer patients." in: Cancer immunology, immunotherapy : CII, Vol. 69, Issue 12, pp. 2533-2546, (2020) (PubMed).

Tominaga, Akiyoshi, Yamamoto, Taguchi, Mori, Nagasaki, Fukunaga, Ueno: "Clinical significance of soluble programmed cell death-1 and soluble programmed cell death-ligand 1 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy." in: PLoS ONE, Vol. 14, Issue 2, pp. e0212978, (2019) (PubMed).

Aghajani, Roberts, Yang, McCafferty, Caixeiro, DeSouza, Niles: "Elevated levels of soluble PD-L1 are associated with reduced recurrence in papillary thyroid cancer." in: Endocrine connections, Vol. 8, Issue 7, pp. 1040-1051, (2019) (PubMed).

Okuma, Wakui, Utsumi, Sagawa, Hosomi, Kuwano, Homma: "Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non-Small-cell Lung Cancer." in: Clinical lung cancer, Vol. 19, Issue 5, pp. 410-417.e1, (2019) (PubMed).